冠状动脉疾病合并糖尿病患者经StentBoost技术指导的经皮冠状动脉介入治疗后5年的随访分析

陈强; 张丽伟; 黄党生; 张春红; 王秋霜; 沈东; 熊敏俊; 杨菲菲

doi:10.24920/003496

Your Location：

Home >

Browse articles >

冠状动脉疾病合并糖尿病患者经StentBoost技术指导的经皮冠状动脉介入治疗后5年的随访分析

中国医学科学杂志（英文版） 2019年34卷第3期页码：177-183

Original Article | Updated：2024-04-10

- 冠状动脉疾病合并糖尿病患者经StentBoost技术指导的经皮冠状动脉介入治疗后5年的随访分析
- Affiliations：
  
  Department of Cardiology, The Fourth Medical Center of Chinese PLA General Hospital, Beijing 100048, China
- Author bio：
  
  *Tel: 86-10-66848113, Fax: 86-10-66867992, E-mail: cardiofeifei115@163.com
- Funds：
  
  Supported by a 304 specific clinical research funding of PLA General Hospital([2016FC-304M-CXYY-04])
- DOI：10.24920/003496
  中图分类号：
- 收稿日期：2019-06-04，
  
  网络出版日期：2019-06-04，
  
  纸质出版日期：2019-06-04
- Accepted：
Scan QR Code
陈强, 张丽伟, 黄党生, 等. 冠状动脉疾病合并糖尿病患者经StentBoost技术指导的经皮冠状动脉介入治疗后5年的随访分析[J]. 中国医学科学杂志（英文版）, 2019,34(3):177-183.

Chen Qiang, Zhang Liwei, Huang Dangsheng, et al. Five-year Clinical Outcomes of CAD Patients Complicated with Diabetes after StentBoost-optimized Percutaneous Coronary Intervention[J]. Chinese medical sciences journal, 2019, 34(3): 177-183.
陈强, 张丽伟, 黄党生, 等. 冠状动脉疾病合并糖尿病患者经StentBoost技术指导的经皮冠状动脉介入治疗后5年的随访分析[J]. 中国医学科学杂志（英文版）, 2019,34(3):177-183. DOI： 10.24920/003496.

Chen Qiang, Zhang Liwei, Huang Dangsheng, et al. Five-year Clinical Outcomes of CAD Patients Complicated with Diabetes after StentBoost-optimized Percutaneous Coronary Intervention[J]. Chinese medical sciences journal, 2019, 34(3): 177-183. DOI： 10.24920/003496.

摘要

目的

评估冠状动脉疾病合并糖尿病患者在经StentBoost技术指导的经皮冠状动脉介入治疗（PCI）后的即刻效果及5年的临床随访结果。

方法

从2009年3月至2010年7月连续入选184例我院接受PCI术的患者

根据是否合并糖尿病将患者分为糖尿病组（

=73

39.67%）和非糖尿病组（

=111

60.33%）。术中植入支架后

通过StentBoost技术发现所有植入支架均存在支架膨胀不全或贴壁不良

经StentBoost技术指引的高压球囊后扩张后

评估两组术后即刻手术效果

并进行5年随访比较两组的临床结局。采用卡方检验或

检验进行组间比较

采用多元回归分析评估影响StentBoost指导的PCI手术远期预后的预测因子。

结果

两组在StentBoost指引的扩张后

最小管腔直径（MinLD）

最大管腔直径（MaxLD）和平均直径较扩张前显著增加（

0.001）

相应地（MaxLD-MinLD）/MaxLD比例和残余狭窄较扩张前显著降低（

0.001）。5年随访结果显示:糖尿病组和非糖尿病组死亡率（4.92%比2.86%

=0.67）

主要不良心脏事件（MACE）率（11.48%比11.43%

=1.0）均相近

但糖尿病组心绞痛复发率较非糖尿病组高（47.54%比29.52%

=0.02）。多因素回归分析提示:年龄和左室射血分数为影响预后的独立预测指标。

结论

StentBoost技术可显著改善即刻的PCI效果。冠状动脉疾病合并糖尿病患者在接受StentBoost技术指导PCI术治疗的远期预后与非糖尿病患者相似。年龄和左室射血分数是预后不良的独立预测指标。

Abstract

Objective

To evaluate the instant effects and five-year clinical outcomes of coronary artery disease patients complicated with diabetes mellitus after StentBoost-optimized percutaneous coronary intervention (PCI).

Methods

From March 2009 to July 2010

184 patients undergoing PCI at our hospital were found stent underexpansion or malapposition by StentBoost after stents implantation and were divided into the diabetic (

=73

39.67%) and the non-diabetic group (

=111

60.33%). All patients received StentBoost-guided post-dilatation after stent implantation. The instant procedural results were measured and clinical outcome after five-year follow-up was analyzed in each group. Between-group comparisons were performed using Chi-square test or Student’s

test. Multivariate logistic regression analysis was carried out to reveal the independent predictors for long-term clinical outcomes of StentBoost-optimized PCI .

Results

After StentBoost-guided post-dilatation

the minimum diameter (MinLD)

maximum diameter (MaxLD) and average diameter in both groups increased significantly than before (

0.001)

the (MaxLD-MinLD)/MaxLD ratio and the in-stent residual stenosis decreased accordingly (

0.001). The five-year follow-up showed similar mortality rate (4.92%

. 2.86%

=0.67) and major adverse cardiac event rate (11.48%

. 11.43%

= 1.0) between the diabetic and the non-diabetic group

whereas the recurrence of angina pectoris was higher in the diabetic group compared to the non-diabetic group (47.54%

. 29.52%;

=0.02). A multivariate logistic regression analysis revealed that age and left ventricular ejection fraction rather than diabetes mellitus were independent predictors for long-term clinical outcomes.

Conclusions

StentBoost could effectively improve instant PCI results; the long-term clinical outcomes of StentBoost-optimized PCI were similar between diabetic and non-diabetic patients. Age and left ventricular ejection fraction were the independent predictors for long-term clinical outcomes.

关键词

Keywords

references

Macisaac RJ , Jerums G . Intensive glucose control and cardiovascular outcomes in type 2 diabetes . Heart Lung Circ 2011 ; 20 ( 10 ): 647 - 54 . doi: 10.1016/j.hlc.2010.07.013 10.1016/j.hlc.2010.07.013 . DOI: 10.1016/j.hlc.2010.07.013 http://doi.org/10.1016/j.hlc.2010.07.013

Gaede P , Lund-Andersen H , Parving HH , et al . Effect of a multifactorial intervention on mortality in type 2 diabetes . N Engl J Med 2008 ; 358 ( 6 ): 580 - 91 . doi: 10.1056/NEJMoa0706245 10.1056/NEJMoa0706245 .

Daemen J , Kuck KH , Macaya C , et al . Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial . J Am Coll Cardiol 2008 ; 52 ( 24 ): 1957 - 67 . doi: 10.1016/j.jacc.2008.09.010 10.1016/j.jacc.2008.09.010 .

Frye RL , August P , Brooks MM , et al . A randomized trial of therapies for type 2 diabetes and coronary artery disease . N Engl J Med 2009 ; 360 ( 24 ): 2503 - 15 . doi: 10.1056/NEJMoa0805796 10.1056/NEJMoa0805796 .

Garg P , Normand SL , Silbaugh TS , et al . Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry . Circulation 2008 ; 118 ( 22 ): 2277 - 85 , p7p following 2285. doi: 10.1161/CIRCULATIONAHA.108.820159 10.1161/CIRCULATIONAHA.108.820159 .

West NE , Ruygrok PN , Disco CM , et al . Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients . Circulation 2004 ; 109 ( 7 ): 867 - 73 . doi: 10.1161/01.CIR.0000116750.63158.94 10.1161/01.CIR.0000116750.63158.94 .

Blackman DJ , Porto I , Shirodaria C , et al . Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis . Am J Cardiol 2004 ; 94 ( 7 ): 922 - 5 . doi: 10.1016/j.amjcard.2004.06.029 10.1016/j.amjcard.2004.06.029 . DOI: 10.1016/j.amjcard.2004.06.029 http://doi.org/10.1016/j.amjcard.2004.06.029

Tasal A , Bacaksiz A , Vatankulu MA , et al . Is postdilatation with a noncompliant balloon necessary after coronary stent deployment during primary angioplasty? . J Interv Cardiol 2013 ; 26 ( 4 ): 325 - 31 . doi: 10.1111/joic.12041 10.1111/joic.12041 .

Rogers RK , Michaels AD . Enhanced x-ray visualization of coronary stents: clinical aspects . Cardiol Clin 2009 ; 27 ( 3 ): 467 - 75 . doi: 10.1016/j.ccl.2009.03.005 10.1016/j.ccl.2009.03.005 . DOI: 10.1016/j.ccl.2009.03.005 http://doi.org/10.1016/j.ccl.2009.03.005

Blicq E , Georges JL , Elbeainy E , et al . Detection of stent underdeployment by StentBoost imaging . J Interv Cardiol 2013 ; 26 ( 5 ): 444 - 53 . doi: 10.1111/joic.12062 10.1111/joic.12062 .

Sarno G , Garg S , Gomez-Lara J , et al . Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study . EuroIntervention 2011 ; 6 ( 8 ): 977 - 84 . doi: 10.4244/EIJV6I8A169 10.4244/EIJV6I8A169 .

Yang FF , Zhang LW , Huang DS , et al . A novel angiographic technique, StentBoost, in comparison with intravascular ultrasound to assess stent expansion . Chin Med J (Engl) 2011 ; 124 ( 6 ): 939 - 42 .

Fysal Z , Hyde T , Barnes E , et al . Evaluating stent optimisation technique (StentBoost®) in a dedicated bifurcation stent (the Tryton™) . Cardiovasc Revasc Med 2014 ; 15 ( 2 ): 92 - 6 . doi: 10.1016/j.carrev.2014.01.002 10.1016/j.carrev.2014.01.002 .

Oh DJ , Choi CU , Kim S , et al . Effect of StentBoost imaging guided percutaneous coronary intervention on mid-term angiographic and clinical outcomes . Int J Cardiol 2013 ; 168 ( 2 ): 1479 - 84 . doi: 10.1016/j.ijcard.2012.12.051 10.1016/j.ijcard.2012.12.051 . DOI: 10.1016/j.ijcard.2012.12.051 http://doi.org/10.1016/j.ijcard.2012.12.051

Silva JD , Carrillo X , Salvatella N , et al . The utility of stent enhancement to guide percutaneous coronary intervention for bifurcation lesions . EuroIntervention 2013 ; 9 ( 8 ): 968 - 74 . doi: 10.4244/EIJV9I8A162 10.4244/EIJV9I8A162 . DOI: 10.4244/EIJV9I8A162 http://doi.org/10.4244/EIJV9I8A162

Agostoni P , Verheye S , Vermeersch P , et al . “Virtual” in-vivo bench test for bifurcation stenting with “StentBoost” . Int J Cardiol 2009 ; 133 ( 2 ): e67 - 9 . doi: 10.1016/j.ijcard.2007.11.018 10.1016/j.ijcard.2007.11.018 .

Agostoni P , Verheye S . Novel self-expanding stent system for enhanced provisional bifurcation stenting: examination by StentBoost and intravascular ultrasound . Catheter Cardiovasc Interv 2009 ; 73 ( 4 ): 481 - 7 . doi: 10.1002/ccd.21878 10.1002/ccd.21878 .

Zhang J , Duan Y , Jin Z , et al . Stent boost subtract imaging for the assessment of optimal stent deployment in coronary ostial lesion intervention: comparison with intravascular ultrasound . Int Heart J 2015 ; 56 ( 1 ): 37 - 42 . doi: 10.1536/ihj.14-169 10.1536/ihj.14-169 .

Mishell JM , Vakharia KT , Ports TA , et al . Determination of adequate coronary stent expansion using StentBoost, a novel fluoroscopic image processing technique . Catheter Cardiovasc Interv 2007 ; 69 ( 1 ): 84 - 93 . doi: 10.1002/ccd.20901 10.1002/ccd.20901 .

Canpolat U , Aytemir K , Yorgun H , et al . Association of type 2 diabetes mellitus with coronary atherosclerotic plaque burden and morphology measured by multidetector computed tomography coronary angiography . Acta Cardiol 2012 ; 67 ( 1 ): 71 - 7 . doi: 10.2143/AC.67.1.2146568 10.2143/AC.67.1.2146568 . DOI: 10.2143/AC.67.1.2146568 http://doi.org/10.2143/AC.67.1.2146568

Aronson D , Bloomgarden Z , Rayfield EJ . Potential mechanisms promoting restenosis in diabetic patients . J Am Coll Cardiol 1996 ; 27 ( 3 ): 528 - 35 . doi: 10.1016/0735-1097(95)00496-3 10.1016/0735-1097(95)00496-3 .

Pasceri V , Pelliccia F , Pristipino C , et al . Clinical effects of routine postdilatation of drug-eluting stents . Catheter Cardiovasc Interv 2014 ; 83 ( 6 ): 898 - 904 . doi: 10.1002/ccd.24999 10.1002/ccd.24999 .

Cheneau E , Satler LF , Escolar E , et al . Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure . Catheter Cardiovasc Interv 2005 ; 65 ( 2 ): 222 - 6 . doi: 10.1002/ccd.20350 10.1002/ccd.20350 .

Arnold SV , Spertus JA , Lipska KJ , et al . Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study . Eur J Prev Cardiol 2015 ; 22 ( 6 ): 779 - 87 . doi: 10.1177/2047487314533622 10.1177/2047487314533622 .

Niccoli G , Montone RA , Lanza GA , et al . Angina after percutaneous coronary intervention: the need for precision medicine . Int J Cardiol 2017 ; 248 : 14 - 9 . doi: 10.1016/j.ijcard.2017.07.105 10.1016/j.ijcard.2017.07.105 .

Sorop O , van den Heuvel M , van Ditzhuijzen NS , et al . Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia . Am J Physiol Heart Circ Physiol 2016 ; 311 ( 6 ): H1339 - H51 . doi: 10.1152/ajpheart.00458.2015 10.1152/ajpheart.00458.2015 .

Zierer J , Pallister T , Tsai PC , et al . Exploring the molecular basis of age-related disease comorbidities using a multi-omics graphical model . Sci Rep 2016 ; 6 : 37646 . doi: 10.1038/srep37646 10.1038/srep37646 .

Daneault B , Genereux P , Kirtane AJ , et al . Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction < 40% versus < /= 40% (from the HORIZONS-AMI trial) . Am J Cardiol 2013 ; 111 ( 1 ): 12 - 20 . doi: 10.1016/j.amjcard.2012.08.040 10.1016/j.amjcard.2012.08.040 . DOI: 10.1016/j.amjcard.2012.08.040 http://doi.org/10.1016/j.amjcard.2012.08.040

Gomadam P , Shah A , Qureshi W , et al . Blood pressure indices and cardiovascular disease mortality in persons with or without diabetes mellitus . J Hypertens 2018 ; 36 ( 1 ): 85 - 92 . doi: 10.1097/HJH.0000000000001509 10.1097/HJH.0000000000001509 .

浏览量

336

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma

Identifying and Validating a Novel miRNA-mRNA Regulatory Network Associated with Prognosis in Lung Adenocarcinoma

Novel Long Non-coding RNA Markers for Prognostic Prediction of Patients with Bladder Cancer

Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials

Postoperative Complications and Survival Analysis of Surgical Resection for Hilar Cholangiocarcinoma: A Retrospective Study of Fifty-Nine Consecutive Patients